Transitional Care Program for Fluid Overload in Cirrhosis

Part of paid clinical trials in Hershey, Pennsylvania.

Sponsor
Milton S. Hershey Medical Center
Study ID
NCT06174272
Status
Recruiting
Apply to this trial

Conditions

  • Cirrhosis, Liver

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Transitional Care Program — BEHAVIORAL
    Intensive monitoring post discharge for cirrhosis and fluid overload

Study Details

The goal of this clinical trial is to learn about an intensive monitoring plan (transitional care program) in patients with cirrhosis and excessive swelling that are going to be discharged from the hospital. The main question\[s\] it aims to answer are: * How much time and what resources are needed to run such a program * How well do patients follow up with the phone calls, bloodwork, and doctor appointments? * Do the patients enrolled in the program have less need for hospitalization later, less kidney injury, better fluid control, and/or better survival compared to patients that are not in the program? Participants will * Be given a digital scale and a binder with educational material and a log to monitor their weights after discharge from the hospital * Receive a phone call from the study team within 72 hours of discharge and weekly * Be given a follow up appointment with hepatology within 4 weeks of discharge Researchers will compare participants in this program to patients that receive normal care to see if there are differences in need for hospitalization later, kidney injury, fluid control, and/or survival.

Key Dates

Start date
Feb 15, 2025
Status verified
Mar 2026
Primary completion
Feb 15, 2027
Completion
Jun 1, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Transitional Care Program
    Participants will receive a digital scale and monitoring log, educational material, a phone call within 72 hours of discharge and weekly for 8 weeks, and a follow up appointment with a hepatologist within 4 weeks of discharge.
  • No Intervention: Standard of Care
    Participants will be given typical discharge and follow up instructions.

Primary Outcome Measure

feasibility of the program [ Time Frame: all 8 weeks of each participant ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Penn State Milton S. Hershey Medical CenterHersheyPennsylvania17033
Alison J Faust, MD
[email protected]
7175311017

Find similar trials in Hershey, PA

By research site
Penn State Milton S. Hershey Medical Center· Hershey, PA

Related Studies